Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology

被引:113
作者
Huber, Walter [1 ]
Mueller, Francis [1 ]
机构
[1] Hoffmann La Roche AG, Dept Pharma Res, CH-4070 Basel, Switzerland
关键词
D O I
10.2174/138161206778743600
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The review gives first an introduction into the basics of surface plasmon resonance technology. The physical principle is shortly discussed followed by a discussion of the experimental details to be considered when using this technology for biomolecular interaction analysis. Based on recent publications it is demonstrated that the technology has widespread applications in many fields of the drug discovery process. Protein/protein interactions can be monitored in real time when working with biopharmaceuticals as well as protein/small analyte interactions during hit finding, secondary screening, lead optimization and lead selection. Equilibrium binding constants, kinetic rate constants and thermodynamic parameters are obtained from such study that helps to understand the mechanism of the binding reactions. This information can be directly used to improve binding properties of a drug candidate.
引用
收藏
页码:3999 / 4021
页数:23
相关论文
共 113 条
[1]   Probing the mechanism of drug/lipid membrane interactions using Biacore [J].
Abdiche, YN ;
Myszka, DG .
ANALYTICAL BIOCHEMISTRY, 2004, 328 (02) :233-243
[2]   High content screening applied to large-scale cell biology [J].
Abraham, VC ;
Taylor, DL ;
Haskins, JR .
TRENDS IN BIOTECHNOLOGY, 2004, 22 (01) :15-22
[3]  
Alanine A, 2003, COMB CHEM HIGH T SCR, V6, P51
[4]   Cholera toxin and GM1:: a model membrane study with IAsys [J].
Athanassopoulou, N ;
Davies, RJ ;
Edwards, PR ;
Yeung, D ;
Maule, CH .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1999, 27 (02) :340-343
[5]  
Bain C. D., 1989, ANGEW CHEM, V101, P522
[6]   Current and emerging commercial optical biosensors [J].
Baird, CL ;
Myszka, DG .
JOURNAL OF MOLECULAR RECOGNITION, 2001, 14 (05) :261-268
[7]  
Benet L.Z., 1996, GOODMAN GILMANS PHAR, V3, P27
[8]  
BHERESFORD IJM, 2002, RADIOISOTOPES BIOL, P233
[9]   Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening [J].
Boehm, HJ ;
Boehringer, M ;
Bur, D ;
Gmuender, H ;
Huber, W ;
Klaus, W ;
Kostrewa, D ;
Kuehne, H ;
Luebbers, T ;
Meunier-Keller, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2664-2674
[10]   Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology [J].
Cannon, MJ ;
Papalia, GA ;
Navratilova, I ;
Fisher, RJ ;
Roberts, LR ;
Worthy, KM ;
Stephen, AG ;
Marchesini, GR ;
Collins, EJ ;
Casper, D ;
Qiu, HW ;
Satpaev, D ;
Liparoto, SF ;
Rice, DA ;
Gorshkova, II ;
Darling, RJ ;
Bennett, DB ;
Sekar, M ;
Hommema, E ;
Liang, AM ;
Day, ES ;
Inman, J ;
Karlicek, SM ;
Ullrich, SJ ;
Hodges, D ;
Chu, T ;
Sullivan, E ;
Simpson, J ;
Rafique, A ;
Luginbühl, B ;
Westin, SN ;
Bynum, M ;
Cachia, P ;
Li, YJ ;
Kao, D ;
Neurauter, A ;
Wong, M ;
Swanson, M ;
Myszka, DG .
ANALYTICAL BIOCHEMISTRY, 2004, 330 (01) :98-113